The slip
PARKINSON RECEIPTno. 13774
29 Oct 2026, 05:24 UTCastrocytes, braak
predictionRASL10A in astrocytes tracks Braak Lewy-body stage
registered1005a6f8b44f7b03
discovery-0.18 p=0.648 n=9
replication+0.16 p=0.680 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.18, p 0.648)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTfdf1cac5db7e8e2c8f72df01…
follows e2e64ac01a75…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 13774: RASL10A in astrocytes, braak
- power
- full sample +0.03 (p 0.901, n 18), 95% CI -0.44 to +0.49. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.03 (p 0.915, n 18). does not hold up.
- composition
- astrocytes share of nuclei vs axis -0.21 (p 0.413); controlling for it: +0.03 (p 0.922, n 18). could be the mix.
- skeptic
- leave-one-out range -0.12 to +0.14, sign flips 5; without severely affected donors +0.03 (p 0.901, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RASL10A in astrocytes.
case closed: nothing better to follow up.